Hypromed 500 Injection contains Hydroxyprogesterone at a concentration of 500 mg/ml, a synthetic progestogen used primarily for its potent progestational activity. This medication is indicated for the prevention of preterm birth in pregnant women with a history of spontaneous preterm delivery and for the management of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance. Hydroxyprogesterone acts by mimicking the natural hormone progesterone, thereby stabilizing the endometrium and maintaining pregnancy. The injection is administered intramuscularly, typically once weekly, with dosing and duration determined by the treating physician based on clinical response and patient condition. Hypromed 500 Injection should be used under strict medical supervision, with caution advised in patients with hepatic impairment, thromboembolic disorders, or hypersensitivity to progestogens. Common adverse effects include injection site reactions, headache, nausea, and dizziness. It is contraindicated in cases of known or suspected breast carcinoma, undiagnosed vaginal bleeding, and active thrombophlebitis. Regular monitoring is recommended to assess therapeutic efficacy and detect potential side effects. Hypromed 500 Injection provides an effective therapeutic option for managing specific gynecological and obstetric conditions requiring progestogen supplementation.